| The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria T Zuberbier, W Aberer, R Asero, AH Abdul Latiff, D Baker, ... Allergy 73 (7), 1393-1414, 2018 | 2108 | 2018 |
| The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria T Zuberbier, AH Abdul Latiff, M Abuzakouk, S Aquilina, R Asero, D Baker, ... Allergy 77 (3), 734-766, 2022 | 633 | 2022 |
| The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update M Maurer, M Magerl, I Ansotegui, E Aygören-Pürsün, S Betschel, K Bork, ... World Allergy Organization Journal 11 (1), 1-20, 2018 | 618 | 2018 |
| WAO guideline for the management of hereditary angioedema T Craig, EA Pürsün, K Bork, T Bowen, H Boysen, H Farkas, A Grumach, ... World Allergy Organization Journal 5 (12), 182-199, 2012 | 433 | 2012 |
| The definition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update … M Magerl, S Altrichter, E Borzova, A Giménez‐Arnau, CEH Grattan, ... Allergy 71 (6), 780-802, 2016 | 401 | 2016 |
| Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity P Staubach, A Eckhardt‐Henn, M Dechene, A Vonend, M Metz, M Magerl, ... British Journal of Dermatology 154 (2), 294-298, 2006 | 328 | 2006 |
| The international WAO/EAACI guideline for the management of hereditary angioedema–The 2021 revision and update M Maurer, M Magerl, S Betschel, W Aberer, IJ Ansotegui, ... World Allergy Organization Journal 15 (3), 100627, 2022 | 292 | 2022 |
| Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence M Maurer, M Metz, R Brehler, U Hillen, T Jakob, V Mahler, C Pföhler, ... Journal of allergy and clinical immunology 141 (2), 638-649, 2018 | 273 | 2018 |
| Development and construct validation of the angioedema quality of life questionnaire K Weller, A Groffik, M Magerl, N Tohme, P Martus, K Krause, M Metz, ... Allergy 67 (10), 1289-1298, 2012 | 264 | 2012 |
| The definition and diagnostic testing of physical and cholinergic urticarias – EAACI/GA2LEN/EDF/UNEV consensus panel recommendations M Magerl, E Borzova, A Giménez‐Arnau, CEH Grattan, F Lawlor, ... Allergy 64 (12), 1715-1721, 2009 | 245 | 2009 |
| Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial A Banerji, MA Riedl, JA Bernstein, M Cicardi, HJ Longhurst, BL Zuraw, ... Jama 320 (20), 2108-2121, 2018 | 240 | 2018 |
| Development, validation, and initial results of the Angioedema Activity Score K Weller, A Groffik, M Magerl, N Tohme, P Martus, K Krause, M Metz, ... Allergy 68 (9), 1185-1192, 2013 | 225 | 2013 |
| New topics in bradykinin research M Maurer, M Bader, M Bas, F Bossi, M Cicardi, M Cugno, P Howarth, ... Allergy 66 (11), 1397-1406, 2011 | 225 | 2011 |
| International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency H Farkas, I Martinez‐Saguer, K Bork, T Bowen, T Craig, M Frank, ... Allergy 72 (2), 300-313, 2017 | 214 | 2017 |
| The German version of the Chronic Urticaria Quality‐of‐Life Questionnaire: factor analysis, validation, and initial clinical findings A Młynek, M Magerl, M Hanna, S Lhachimi, I Baiardini, GW Canonica, ... Allergy 64 (6), 927-936, 2009 | 214 | 2009 |
| Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial P Staubach, K Onnen, A Vonend, M Metz, F Siebenhaar, I Tschentscher, ... Dermatology 212 (2), 150-159, 2006 | 212 | 2006 |
| Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. BL Zuraw, K Bork, KE Binkley, A Banerji, SC Christiansen, A Castaldo, ... Allergy & Asthma Proceedings 33 (6), 2012 | 208 | 2012 |
| Plasticity and cytokinetic dynamics of the hair follicle mesenchyme: implications for hair growth control DJ Tobin, M Magerl, A Gunin, B Handijski, R Paus Journal of investigative dermatology 120 (6), 895-904, 2003 | 199 | 2003 |
| Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria M Metz, S Altrichter, E Ardelean, B Keβler, K Krause, M Magerl, ... International archives of allergy and immunology 154 (2), 177-180, 2011 | 192 | 2011 |
| High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria P Staubach, M Dechene, M Metz, M Magerl, F Siebenhaar, K Weller, ... Acta dermato-venereologica 91 (5), 557-561, 2011 | 180 | 2011 |
Marcus MaurerProfessor, Institute of Allergology, Charité - Universitätsmedizin Berlin, GermanyVerified email at charite.de
